Cytomegalovirus Infection in Pregnancy: Prevention, Presentation, Management and Neonatal Outcomes

Megan H Pesch, Natalie A Saunders, Samia Abdelnabi, Megan H Pesch, Natalie A Saunders, Samia Abdelnabi

Abstract

Congenital cytomegalovirus (cCMV) is the most common congenital infection in the United States, with 1 of 200 live births affected. It is the leading viral cause of intrauterine fetal demise and miscarriage. It is a common cause of neonatal hearing loss, second only to genetic factors. Yet, health care provider awareness remains low. The purpose of this article is to provide a brief overview of the epidemiology, presentation, diagnosis, and treatment of antenatal cytomegalovirus (CMV) infection and cCMV in the neonate. Maternal CMV infection in pregnancy often presents with mild cold-like symptoms or is asymptomatic. The virus can be vertically transmitted to a growing fetus, the risk of transmission and severity of fetal impact varying by timing of exposure during pregnancy. Most neonates born with cCMV show no signs at birth, yet 15% to 25% will have long-term adverse neurodevelopmental conditions. Misconceptions that cCMV cannot be prevented or that neonates born without signs of the disease will be unaffected are common. Evidence supporting antenatal education around behavioral change to lower a woman's risk of acquiring CMV during pregnancy is mounting. CMV infection during pregnancy should be co-managed with a maternal-fetal medicine specialist. There is early evidence for the use of antiviral medication in reducing risk of vertical transmission. Identification of cCMV during pregnancy may help ensure the neonate receives timely treatment after birth. Midwives can play an important role in providing antenatal education about cCMV risk reduction and in initiating a diagnostic evaluation when there is clinical suspicion.

Keywords: CMV; congenital cytomegalovirus; cytomegalovirus; fetal infection.

© 2021 by the American College of Nurse-Midwives.

References

REFERENCES

    1. Boppana SB, Ross SA, Fowler KB. Congenital cytomegalovirus infection: clinical outcome. Clin Infect Dis. 2013;57(suppl 4):S178-S181.
    1. Manicklal S, Emery VC, Lazzarotto T, Boppana SB, Gupta RK. The “silent” global burden of congenital cytomegalovirus. Clinical Microbiol Rev. 2013;26(1):86-102.
    1. Page JM, Bardsley T, Thorsten V, et al. Stillbirth associated with infection in a diverse U.S. cohort. Obstet Gynecol. 2019;134(6):1187-1196.
    1. Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177-e188.
    1. Pesch MH, Anderson C, Mowers E. Improving obstetric provider congenital cytomegalovirus knowledge and practices. Infectious Dis Obstet Gynecol. 2020;2020:8875494.
    1. Barber V, Calvert A, Vandrevala T, et al. Prevention of acquisition of cytomegalovirus infection in pregnancy through hygiene-based behavioural interventions: a systematic review and gap analysis. Ped Infect Dis J. 2020;39(10):949-954.
    1. Cordier A, Guitton S, Vauloup-Fellous C, Grangeot-Keros L, Benachi A, Picone O. Awareness and knowledge of congenital cytomegalovirus infection among health care providers in France. J Clin Virol. 2012;55(2):158-163.
    1. Leruez-Ville M, Foulon I, Pass R, Ville Y. Cytomegalovirus infection during pregnancy: state of the science. Am J Obstet Gynecol. 2020: 223(3):330-349.
    1. Chatzakis C, Ville Y, Makrydimas G, Dinas K, Zavlanos A, Sotiriadis A. Timing of primary maternal cytomegalovirus infection and rates of vertical transmission and fetal consequences. Am J Obstet Gynecol. 2020;223(6):87-883.e11.
    1. Bartlett AW, McMullan B, Rawlinson WD, Palasanthiran P. Hearing and neurodevelopmental outcomes for children with asymptomatic congenital cytomegalovirus infection: a systematic review. Rev Med Virol. 2017;27(5):e1938.
    1. Lanzieri TM, Leung J, Caviness AC, et al. Long-term outcomes of children with symptomatic congenital cytomegalovirus disease. J Perinatol. 2017;37(7):875-880.
    1. Fowler KB, Ross SA, Shimamura M, et al. Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection. J Pediatr. 2018;200:196-201.e191.
    1. Grosjean J, Trapes L, Hantz S, et al. Human cytomegalovirus quantification in toddlers saliva from day care centers and emergency unit: a feasibility study. J Clin Virol. 2014;61(3):371-377.
    1. Cheeran MCJ, Lokensgard JR, Schleiss MR. Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention. Clin Microbiol Rev. 2009;22(1):99-126.
    1. Royal Australian and New Zealand Gynaecologists and Obstetricians. Prevention of Congenital Cytomegalovius Infection. Royal Australian and New Zealand Gynaecologists and Obstetricians; 2019.
    1. Practice bulletin no. 151: cytomegalovirus, parvovirus B19, varicella zoster, and toxoplasmosis in pregnancy. Obstet Gynecol. 2015;125(6):1510.
    1. Revello MG, Tibaldi C, Masuelli G, et al. Prevention of primary cytomegalovirus infection in pregnancy. EBioMedicine. 2015;2(9):1205-1210.
    1. Price SM, Bonilla E, Zador P, Levis DM, Kilgo CL, Cannon MJ. Educating women about congenital cytomegalovirus: assessment of health education materials through a web-based survey. BMC Womens Health. 2014;14:144.
    1. Schaefer MR, Holttum J, Olson M, et al. Development and assessment of a prenatal cytomegalovirus (CMV) educational survey: implementation and impact in a metropolitan university-based clinic. J Womens Health. 2020;12:1205-1214.
    1. Vandrevala T, Barber V, Mbire-Chigumba E, et al. Parenting a child with congenital cytomegalovirus infection: a qualitative study. BMJ Paediatr Open. 2020;4(1)e000844.
    1. Luck SE, Wieringa JW, Blázquez-Gamero D, et al. Congenital cytomegalovirus: a European expert consensus statement on diagnosis and management. Ped Infect Dis J. 2017;36(12):1205-1213.
    1. Navti OB, Al-Belushi FM, Konje JC; FRCOG. Cytomegalovirus infection in Pregnancy-an update. Eur J Obestet Gynecol Reproduc Biol. 2020;258:216-222.
    1. Society for Maternal-Fetal Medicine (SMFM); Hughes BL, Gyamfi-Bannerman C. Diagnosis and antenatal management of congenital cytomegalovirus infection. Am J Obstet Gynecol. 2016;214(6):B5-B11.
    1. Shahar-Nissan K, Pardo J, Peled O, et al. Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial. Lancet. 2020;396(10253):779-785.
    1. Stehel EK, Sánchez PJ. Cytomegalovirus infection in the fetus and neonate. Neoreviews. 2005;6(1):e38-e45.
    1. Johan J. Eyes wide open. Flickr via Creative Commons. 2007. Accessed: 13 January 2021.
    1. Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17(6):e177-e188.
    1. Kimberlin DW, Jester PM, Sánchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. New Engl J Med. 2015;372(10):933-943.
    1. Kylat RI, Kelly EN, Ford-Jones EL. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus infection. Eur J Pediatr. 2006;165(11):773-778.
    1. Sakamoto A, Moriuchi H, Matsuzaki J, Motoyama K, Moriuchi M. Retrospective diagnosis of congenital cytomegalovirus infection in children with autism spectrum disorder but no other major neurologic deficit. Brain Dev. 2015;37(2):200-205.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit